Halma (LON:HLMA) Hits New 52-Week High - Should You Buy?

Halma plc (LON:HLMA - Get Free Report) shares hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 3,342 ($45.50) and last traded at GBX 3,272 ($44.55), with a volume of 24374285 shares. The stock had previously closed at GBX 3,020 ($41.12).

Analyst Upgrades and Downgrades

Separately, Shore Capital restated a "hold" rating on shares of Halma in a research note on Thursday, March 13th.

Halma Trading Up 3.3%

The firm has a market capitalization of £11.75 billion, a P/E ratio of 43.64, a PEG ratio of 2.93 and a beta of 0.53. The company has a quick ratio of 1.51, a current ratio of 2.45 and a debt-to-equity ratio of 45.83. The stock has a fifty day simple moving average of GBX 2,792.92 and a 200 day simple moving average of GBX 2,778.12.

Halma (LON:HLMA - Get Free Report) last issued its quarterly earnings results on Thursday, June 12th. The company reported GBX 94.23 ($1.28) earnings per share (EPS) for the quarter. Halma had a return on equity of 15.87% and a net margin of 13.21%. As a group, research analysts forecast that Halma plc will post 90.5626134 EPS for the current year.

Insider Transactions at Halma

In other news, insider Steve Gunning bought 267 shares of the firm's stock in a transaction that occurred on Thursday, March 27th. The stock was purchased at an average price of GBX 2,619 ($35.66) per share, with a total value of £6,992.73 ($9,520.39). Insiders own 2.20% of the company's stock.

Halma Company Profile

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in: - Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety. - Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research. - Health - Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes. Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.